Prof. HAKAN GÖKER

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Asymptomatic unilateral phrenic nerve palsy after bortezomib treatment in a newly diagnosed multiple myeloma patient

Coskunpinar M., Erdogdu B., GÖKER H.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.29, no.2, pp.502-505, 2023 (SCI-Expanded)

Hypophosphatemia related to the use of ibrutinib

KARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.

Journal of Oncology Pharmacy Practice, 2023 (SCI-Expanded)

A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.

Turkish Journal of Medical Sciences, vol.53, no.1, pp.352-359, 2023 (SCI-Expanded)

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.

MEDICINA-LITHUANIA, vol.58, no.11, 2022 (SCI-Expanded)

Validity and reliability of the Turkish version of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) quality of life questionnaire in patients undergoing bone marrow transplantation

YILDIZ KABAK V., Demircioglu A., Aladag E., KARAHAN S., GÖKER H., ATASAVUN UYSAL S., et al.

Palliative and Supportive Care, vol.20, no.4, pp.556-563, 2022 (SSCI)

Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study

BALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.33, no.7, pp.615-624, 2022 (SCI-Expanded)

Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study

Akpinar S., Tekgunduz E., Esen R., YILMAZ M., Karakus V., VURAL F., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.61, no.1, 2022 (SCI-Expanded)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.52, no.2, pp.413-419, 2022 (SCI-Expanded)

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, vol.32, no.4, pp.209-213, 2022 (SCI-Expanded) Sustainable Development

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.32, no.1, pp.65-67, 2022 (SCI-Expanded)

Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.60, no.2, 2021 (SCI-Expanded)

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.

CARDIOVASCULAR TOXICOLOGY, vol.21, no.3, pp.216-223, 2021 (SCI-Expanded)

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.21, no.3, pp.147-153, 2021 (SCI-Expanded)

Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., GÖKER H.

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.2, pp.138-144, 2021 (SCI-Expanded)

Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience

Yilmaz F., SOYER N., Seval G. C., Bozdag S. C., TOPÇUOĞLU P., ÜNAL A., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.3, pp.195-203, 2021 (SCI-Expanded)

Central nervous system involvement in patients with acute myeloid leukemia

YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.5, pp.2351-2356, 2021 (SCI-Expanded)

Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation

ALADAĞ KARAKULAK E., GÖKER H., BÜYÜKAŞIK Y., DEMİROĞLU H.

TRANSPLANTATION PROCEEDINGS, vol.53, no.1, pp.391-395, 2021 (SCI-Expanded)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.

OPEN MEDICINE, vol.16, no.1, pp.192-197, 2021 (SCI-Expanded)

Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma

DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., GÖKER H.

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.3, pp.204-210, 2021 (SCI-Expanded)

Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.1, pp.355-358, 2021 (SCI-Expanded)

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.38, no.1, pp.33-40, 2021 (SCI-Expanded)

Effects of partly supervised and home-based exercise program in patients undergoing hematopoietic stem cell transplantation: a case-control study

YILDIZ KABAK V., GÖKER H., DÜGER T.

SUPPORTIVE CARE IN CANCER, vol.28, no.12, pp.5851-5860, 2020 (SCI-Expanded)

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.

Transfusion and Apheresis Science, vol.59, no.5, 2020 (SCI-Expanded)

Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

BEKSAÇ M., Aydin Y., GÖKER H., Turgut M., Besisik S. K., Cagirgan S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.20, no.8, 2020 (SCI-Expanded)

Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.4, 2020 (SCI-Expanded)

Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.2, 2020 (SCI-Expanded)

Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors

OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.

LEUKEMIA & LYMPHOMA, vol.61, pp.50-52, 2020 (SCI-Expanded)

Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience

GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.1, 2020 (SCI-Expanded)

Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.1, 2020 (SCI-Expanded)

The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., TOPÇU M., Gevher N., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.1, 2020 (SCI-Expanded)

Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience

Ozbalak M., SALİHOĞLU A., Soysal T., Karadogan I., PAYDAŞ S., Ozdemir E., et al.

ANNALS OF HEMATOLOGY, vol.99, no.2, pp.301-307, 2020 (SCI-Expanded)

Acute Graft-Versus-Host Disease: A Brief Review

ALADAĞ KARAKULAK E., KELKİTLİ E., GÖKER H.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.1, pp.1-4, 2020 (SCI-Expanded)

The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy

Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, vol.42, no.1, pp.17-21, 2020 (SCI-Expanded)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.4, pp.256-262, 2020 (SCI-Expanded)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.37, no.2, pp.116-120, 2020 (SCI-Expanded)

What is the role of the decrease in immunoglobulin level after the first cycle in patient with multiple myeloma?

GÖKER H., KELKİTLİ E., Turgut M.

AMERICAN JOURNAL OF HEMATOLOGY, vol.94, 2019 (SCI-Expanded)

SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA

ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.

AMERICAN JOURNAL OF HEMATOLOGY, vol.94, 2019 (SCI-Expanded)

Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.11, pp.729-734, 2019 (SCI-Expanded)

Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., DEMİROĞLU H.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol.35, no.4, pp.655-661, 2019 (SCI-Expanded)

Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

BEKSAÇ M., Seval G. C., PAYDAŞ S., Tuglular T. F., ARSLAN Ö., GÖKER H., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.10, 2019 (SCI-Expanded)

Mantle cell lymphoma: a Turkish Multi-Center Study

OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.

JOURNAL OF BUON, vol.24, no.5, pp.2084-2089, 2019 (SCI-Expanded)

Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE, vol.58, no.3, pp.313-317, 2019 (SCI-Expanded)

Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors

Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.

BONE MARROW TRANSPLANTATION, vol.54, no.4, pp.595-600, 2019 (SCI-Expanded) Sustainable Development

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.19, no.3, pp.177-182, 2019 (SCI-Expanded)

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.5, pp.1560-1563, 2019 (SCI-Expanded)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.4, pp.985-992, 2019 (SCI-Expanded)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.36, no.2, pp.88-96, 2019 (SCI-Expanded)

Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.12, no.7, pp.9288-9294, 2019 (SCI-Expanded)

Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.6, pp.752-755, 2018 (SCI-Expanded)

Hematopoietic stem cell transplantation in geriatric patients in Turkey

GÖKER H., KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H.

TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.2, pp.159-162, 2018 (SCI-Expanded)

Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.28, no.4, pp.254-260, 2018 (SCI-Expanded)

Biosimilar filgrastim (leucostim (R)) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen (R)) and lenograstim (granocyte (R)): A retrospective multicenter study

Kayikci O., Tekgunduz E., Kaya A. H., GÖKER H., Aslan A., Iskender D., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.56, no.6, pp.832-835, 2017 (SCI-Expanded)

Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)

Tekgunduz E., Arat M., GÖKER H., Ozdogu H., KAYNAR L., Cagirgan S., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.56, no.6, pp.845-849, 2017 (SCI-Expanded)

Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Tekgunduz E., DEMİRKAN F., VURAL F., GÖKER H., Ozdogu H., KİKİ İ., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.56, no.6, pp.804-808, 2017 (SCI-Expanded)

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.34, no.1, pp.103-104, 2017 (SCI-Expanded)

Reversible diffusion restriction of optic radiations: A distinct form of cyclosporine induced leukoencephalopathy presenting with visual loss

GÖÇMEN R., Colpak A. I., GÖKER H., Kaya A. A., Onder H.

JOURNAL OF THE NEUROLOGICAL SCIENCES, vol.366, pp.155-157, 2016 (SCI-Expanded)

Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience

Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.16, no.5, pp.269-274, 2016 (SCI-Expanded)

Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT

Giebel S., Labopin M., Ibatici A., Browne P., Czerw T., Socie G., et al.

ONCOLOGIST, vol.21, no.3, pp.377-383, 2016 (SCI-Expanded)

Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates

Tekgunduz E., Sencan I., Kapuagasi A., Unal D., Oztturk M., Gumus E., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.54, no.1, pp.53-59, 2016 (SCI-Expanded)

Chimeric antigen receptor T cell treatment in hematologic malignancies

GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE, vol.54, no.1, pp.35-40, 2016 (SCI-Expanded)

Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice

Tekgunduz E., KAYNAR L., GÖKER H., Kaya A. H., ERMİŞ TURAK E., ELİAÇIK E., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.54, no.1, pp.41-47, 2016 (SCI-Expanded)

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.12-19, 2016 (SCI-Expanded)

The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.1, pp.54-60, 2016 (SCI-Expanded)

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.2, pp.119-126, 2016 (SCI-Expanded)

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.4, pp.281-285, 2016 (SCI-Expanded)

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.26, no.3, pp.153-158, 2016 (SCI-Expanded)

Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.

HEMATOLOGY, vol.20, no.7, pp.392-396, 2015 (SCI-Expanded)

High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY, vol.102, no.2, pp.211-217, 2015 (SCI-Expanded)

Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor

GÖKER H., ETGÜL S., BÜYÜKAŞIK Y.

TRANSFUSION AND APHERESIS SCIENCE, vol.53, no.1, pp.23-29, 2015 (SCI-Expanded)

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

Salihoglu A., Elverdi T., KARADOGAN I., PAYDAŞ S., ÖZDEMİR E., ERDEM G., et al.

ANNALS OF HEMATOLOGY, vol.94, no.3, pp.415-420, 2015 (SCI-Expanded)

Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22515-22519, 2015 (SCI-Expanded)

The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.8, no.12, pp.22564-22569, 2015 (SCI-Expanded)

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA, vol.134, no.1, pp.32-37, 2015 (SCI-Expanded)

Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.25, no.4, pp.215-221, 2015 (SCI-Expanded)

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.32, no.2, pp.163-167, 2015 (SCI-Expanded)

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD, vol.124, no.21, 2014 (SCI-Expanded) Sustainable Development

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD, vol.124, no.21, 2014 (SCI-Expanded)

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.31, no.2, pp.136-142, 2014 (SCI-Expanded)

Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Yeshurun M., Labopin M., Blaise D., Cornelissen J. J., Sengeloev H., Vindelov L., et al.

CANCER, vol.120, no.6, pp.855-863, 2014 (SCI-Expanded)

Ibrutinib: From Molecule to Medicine

Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.4-14, 2014 (SCI-Expanded)

Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population

Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.190-194, 2014 (SCI-Expanded)

Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.4, pp.253-259, 2014 (SCI-Expanded)

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.24, no.3, pp.213-216, 2014 (SCI-Expanded)

Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.30, no.4, pp.400-404, 2013 (SCI-Expanded)

Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, vol.14, no.4, pp.308-314, 2013 (SCI-Expanded)

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.

TRANSFUSION AND APHERESIS SCIENCE, vol.49, no.3, pp.590-599, 2013 (SCI-Expanded)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.30, no.3, pp.328-330, 2013 (SCI-Expanded)

EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.

HEMATOLOGY, vol.18, no.5, pp.247-252, 2013 (SCI-Expanded)

ULTRASTRUCTURAL ANALYSES OF THE NOVEL CHIMERIC HEMOSTATIC AGENT GENERATED VIA NANOTECHNOLOGY, ABS NANOHEMOSTAT, AT THE RENAL TISSUE LEVEL

Huri E., HAZNEDAROĞLU İ. C., Hayran M., Ergun M., FIRAT A., Beyazit Y., et al.

HAEMATOLOGICA, vol.98, pp.439, 2013 (SCI-Expanded)

Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.19, no.3, pp.338-340, 2013 (SCI-Expanded)

Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia

BOZKURT S., Uz B., BÜYÜKAŞIK Y., BEKTAŞ Ö., Inanc A., GÖKER H., et al.

MEDICAL ONCOLOGY, vol.30, no.1, 2013 (SCI-Expanded)

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.264-268, 2013 (SCI-Expanded)

Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.

ACTA HAEMATOLOGICA, vol.130, no.3, pp.199-205, 2013 (SCI-Expanded)

Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.23, no.4, pp.260-263, 2013 (SCI-Expanded)

Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT

Nagler A., Labopin M., Shimoni A., Mufti G. J., Cornelissen J. J., Blaise D., et al.

EUROPEAN JOURNAL OF HAEMATOLOGY, vol.89, no.3, pp.206-213, 2012 (SCI-Expanded)

Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.1-7, 2012 (SCI-Expanded)

Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.1, pp.46-50, 2012 (SCI-Expanded)

A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers

Balcik O. S., Koroglu M., Cipil H., Kaftan O., Maral S., Gurel A., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.22, no.4, pp.267-274, 2012 (SCI-Expanded)

Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.28, no.3, pp.223-227, 2011 (SCI-Expanded)

Surgical and histopathological effects of topical Ankaferd (R) hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure

Ulus A. T., TURAN DURAL N. N., Ozyalcin S., Aydog G., Ulus F., GÖKER H., et al.

TURKISH JOURNAL OF HEMATOLOGY, vol.28, no.3, pp.206-212, 2011 (SCI-Expanded)

Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation

YALÇIN S. S., Kondolot M., GÖKER H., KUŞKONMAZ B. B., Karacan Y., ÇETİN M., et al.

EPIDEMIOLOGY AND INFECTION, vol.139, no.5, pp.683-687, 2011 (SCI-Expanded) Sustainable Development

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

BEKSAÇ M., HAZNEDAR R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.

EUROPEAN JOURNAL OF HAEMATOLOGY, vol.86, no.1, pp.16-22, 2011 (SCI-Expanded)

Topical Ankaferd Bloodstopper in the Management of Critical Bleedings due to Hemorrhagic Diathesis

Turgut M., Tutkun F., Celebi N., MUĞLALI M., HAZNEDAROĞLU İ. C., GÖKER H.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.21, no.3, pp.160-165, 2011 (SCI-Expanded)

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, vol.8, no.1, pp.30-38, 2011 (SCI-Expanded)

A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia

Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.

MEDICAL PRINCIPLES AND PRACTICE, vol.20, no.4, pp.341-344, 2011 (SCI-Expanded)

Evaluation of Hemostatic Effects of Ankaferd as an Alternative Medicine

Beyazit Y., Kurt M., Kekilli M., GÖKER H., HAZNEDAROĞLU İ. C.

ALTERNATIVE MEDICINE REVIEW, vol.15, no.4, pp.329-336, 2010 (SCI-Expanded)

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH, vol.34, no.12, 2010 (SCI-Expanded)

Determination of burnout levels of nurses working in stem cell transplantation units in Turkey

AKKUŞ Y., Karacan Y., GÖKER H., AKSU S.

NURSING & HEALTH SCIENCES, vol.12, no.4, pp.444-449, 2010 (SCI-Expanded)

Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an In Vivo Rabbit Experimental Model

Bilgili H., Captug O., Kosar A., Kurt M., Kekilli M., Shorbagi A., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.16, no.5, pp.533-536, 2010 (SCI-Expanded)

Serological response to influenza vaccine after hematopoetic stem cell transplantation

YALÇIN Ş., Kondolot M., Albayrak N., Altas A. B., Karacan Y., Kuskonmaz B. B., et al.

ANNALS OF HEMATOLOGY, vol.89, no.9, pp.913-918, 2010 (SCI-Expanded) Sustainable Development

Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper

HAZNEDAROGLU B. Z., HAZNEDAROĞLU İ. C., WALKER S. L., Bilgili H., GÖKER H., Kosar A., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.16, no.4, pp.446-453, 2010 (SCI-Expanded)

Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas

Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.96-102, 2010 (SCI-Expanded)

Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens

SARIBAŞ Z., ŞENER B., HAZNEDAROĞLU İ. C., Hascelik G., Kirazli S., GÖKER H.

CENTRAL EUROPEAN JOURNAL OF MEDICINE, vol.5, no.2, pp.198-202, 2010 (SCI-Expanded)

Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery

ERCETIN S., HAZNEDAROĞLU İ. C., Kurt M., ONAL I. K., AKTAŞ A., KURT O. K., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.1, pp.1-5, 2010 (SCI-Expanded)

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.

MEDICAL ONCOLOGY, vol.27, no.1, pp.55-58, 2010 (SCI-Expanded)

The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.25-26, 2010 (SCI-Expanded)

Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.20, no.2, pp.13-16, 2010 (SCI-Expanded)

Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

INTERNAL MEDICINE, vol.49, no.22, pp.2493-2497, 2010 (SCI-Expanded)

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

ANNALS OF HEMATOLOGY, vol.88, no.7, pp.667-671, 2009 (SCI-Expanded)

In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin

Cipil H. S., Kosar A., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.15, no.3, pp.270-276, 2009 (SCI-Expanded)

The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model

Kosar A., Cipil H. S., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.

BLOOD COAGULATION & FIBRINOLYSIS, vol.20, no.3, pp.185-190, 2009 (SCI-Expanded)

The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey

Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.29, no.2, pp.388-394, 2009 (SCI-Expanded)

Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.101, no.4, pp.370-372, 2009 (SCI-Expanded)

In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract

Akkoc N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.29, no.2, pp.410-415, 2009 (SCI-Expanded)

Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.101, no.3, pp.270-272, 2009 (SCI-Expanded)

Hemostatic Efficacy of Ankaferd Blood Stopper (R) in a Swine Bleeding Model

Bilgili H., Kosar A., Kurt M., Onal I. K., GÖKER H., Captug O., et al.

MEDICAL PRINCIPLES AND PRACTICE, vol.18, no.3, pp.165-169, 2009 (SCI-Expanded)

Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma

Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.

ONKOLOGIE, vol.32, no.11, pp.662-664, 2009 (SCI-Expanded)

Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper Response

HAZNEDAROĞLU İ. C., GÖKER H.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol.36, no.6, pp.1448-1449, 2008 (SCI-Expanded)

Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.

BLOOD COAGULATION & FIBRINOLYSIS, vol.19, no.7, pp.633-637, 2008 (SCI-Expanded)

Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.

ANNALS OF HEMATOLOGY, vol.87, no.10, pp.853-854, 2008 (SCI-Expanded)

Evidence for higher red blood cell mass in persons with unconjugated Hyperbilirubinemia and Gilbert's syndrome

BÜYÜKAŞIK Y., Akman U., Buyukasik N. S., GÖKER H., Kilicarslan A., Shorbagi A. I., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, vol.335, no.2, pp.115-119, 2008 (SCI-Expanded)

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.100, no.1, pp.86-90, 2008 (SCI-Expanded)

Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease

Koca E., Haznedaroglu I. C., ÜNER A., Sayinalp N., Saglam A. E., Goker H., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.99, no.11, pp.1243-1246, 2007 (SCI-Expanded)

Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia

Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.

AMERICAN JOURNAL OF HEMATOLOGY, vol.82, no.4, pp.333, 2007 (SCI-Expanded)

Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes

Coskun S., Atalar E., Ozturk E., Yavuz B., Ozer N., Goker H., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.98, no.11, pp.1746-1750, 2006 (SCI-Expanded)

Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML

Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.

LEUKEMIA & LYMPHOMA, vol.47, no.5, pp.891-896, 2006 (SCI-Expanded)

Couda equina syndrome as a rare manifestation of leukemia relapse during postallograft period

Önal I. K., Shorbagi A., GÖKER H., Büyükasyk Y., ÖZÇAKAR L., Tufan A., et al.

Journal of the National Medical Association, vol.98, no.5, pp.808-810, 2006 (SCI-Expanded)

Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature

Nuamah N. M., GÖKER H., Kilic Y. A., Dagmoura H., ÇAKMAK A.

HAEMATOLOGICA, vol.91, pp.26-28, 2006 (SCI-Expanded)

Synthesis and crystal structure elucidation of 1-(4-fluorobenzyl)-2-(4-cyanophenyl)-1H-benzimidazole-5-carbonitrile

Ozbey S., KAYNAK F. B., GOKER H., KUS C.

JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, vol.34, no.12, pp.851-858, 2004 (SCI-Expanded)

2-(2,4-Dichlorophenyl)-5-fluoro-6-morpholin-4-yl-1H-benzimidazole monohydrate

Ozbey S., KAYNAK F. B., KUS C., GOKER H.

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, vol.58, 2002 (SCI-Expanded)

Crystal structure of 1-cyclopropyl-2-ethyl-5-fluoro-6-(4-methylpiperazin-1-yl)-1H-benzimidazole

Ozbey S., KUS C., GOKER H.

ANALYTICAL SCIENCES, vol.17, no.8, pp.1019-1020, 2001 (SCI-Expanded)

Synthesis and antihistaminic H-1 activity of 1,2,5(6)-trisubstituted benzimidazoles

GOKER H., AYHAN-KILCIGIL G., TUNCBILEK M. G., KUS C., ERTAN R., KENDI E., et al.

HETEROCYCLES, vol.51, no.11, pp.2561-2573, 1999 (SCI-Expanded)

2,5-dichloro-1-(p-chlorobenzyl)-1H-benzimidazole

KENDI E., Ozbey S., GOKER H.

ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol.55, pp.243-245, 1999 (SCI-Expanded)

1-benzyl-2-(2,6-dichloroanilinomethyl)-1H-benzimidazole

KENDI E., Ozbey S., TUNCBILEK M. G., GOKER H.

ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol.54, pp.854-856, 1998 (SCI-Expanded)

The structure of 1-(p-fluorophenylmethyl)-2-(4-methyl-1-piperazinyl)-1H-benzimidazole hydrogen fumarate

Ozbey S., KENDI E., GOKER H., TUNCBILEK M. G.

JOURNAL OF CHEMICAL CRYSTALLOGRAPHY, vol.28, no.6, pp.461-464, 1998 (SCI-Expanded)

2-(2-ethoxycarbonyl-1,4-benzodioxan-7-yl)-4H-1-benzopyran-4-one

Ozbey S., KENDI E., GOKER H., ERTAN R.

ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, vol.53, pp.1981-1983, 1997 (SCI-Expanded)

Synthesis of some new benzimidazole-5(6)-carboxylic acids

GOKER H., OLGEN S., ERTAN R., AKGUN H., Ozbey S., KENDI E., et al.

JOURNAL OF HETEROCYCLIC CHEMISTRY, vol.32, no.6, pp.1767-1773, 1995 (SCI-Expanded)

Articles Published in Other Journals

Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

HEMATOLOGY REPORTS, vol.12, no.1, 2020 (ESCI)

DETERMINANTS OF CARDIORESPIRATORY FITNESS LEVEL IN HEMATOPOIETIC STEM CELL TRANSPLANTATION CANDIDATES

YILDIZ KABAK V., GÖKER H., ATASAVUN UYSAL S., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., et al.

TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI, vol.30, no.2, pp.81-88, 2019 (ESCI)

Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

Journal of Global Oncology, pp.205, 2018 (ESCI)

Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case

Malkan U. Y., GÜNEŞ G., DEMİROĞLU H., GÖKER H.

HEMATOLOGY REPORTS, vol.10, no.4, pp.96-97, 2018 (ESCI)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease

GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.

CASE REPORTS IN HEMATOLOGY, 2015 (ESCI)

THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.74, no.1, pp.7-12, 2011 (ESCI)

DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.73, no.3, pp.74-79, 2010 (ESCI)

Refereed Congress / Symposium Publications in Proceedings

Proceedings of the World Congress of Gastroenterology

BALABAN H. Y., ASLAN A. T., AKDOĞAN KİTTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.

World Congress of Gastroenterology, İstanbul, Turkey, 21 September 2019, vol.30, pp.729

Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.254-255

AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITHRESPECT TO RELAPSE FOLLOWING TRANSPLANTATION

DEMİROĞLU H., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÜL Ö., BÜYÜKAŞIK Y., et al.

24th EHA Congress, 13 - 16 June 2019, vol.3, pp.941-942

THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.

15th International Conference on Malignant Lymphoma, Switzerland, 18 - 22 June 2019, vol.37, pp.366

HEMATOLOJİK MALİGNİTELERDE DONÖR LENFOSİT İNFÜZYONU ÖNCESİ VERİLEN KEMOTERAPİ SİKLUS SAYISININ SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019

ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.

4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 4 - 06 April 2019

Hematopoietic Stem Cell Transplantation for HIV-positive Patients with Hematologic MAlignancies: Three Patients Experience from Turkey

Çiftçiler R., GÖKER H., İNKAYA A. Ç., ÜNAL S., DEMİROĞLU H.

International Forum on Infectious Diseases, İstanbul, Turkey, 21 - 24 March 2019, pp.11-14 Sustainable Development

MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.

3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Turkey, 8 - 09 March 2019

Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.

ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.

16. Ulusal Hepato Gastroenteroloji Kongresi, Girne, Cyprus (Kktc), 31 October 2018 Sustainable Development

Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

Analysis of Elderly Patients with Chronic Myeloid Leukemia

KELKİTLİ E., GÖKER H., Turgut M., ATAY M. H.

60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132

PHİLADELPHİA KROMOZOMU POZİTİF AKUT MYELOİDLÖSEMİLİ OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H., DEMİROĞLU H., BÜYÜKAŞIK Y.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.340

DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.364-365 Sustainable Development

AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.261

PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU

DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.

TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018

LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018

MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.

44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 31 October - 03 November 2018, pp.266

T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Turkey, 31 October - 03 November 2018

BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE

DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.

IX. INTERNATIONAL EHOC, 17 - 20 October 2018, vol.73

Extramedullary relapse of the AML following allo-HSCT: a case repor

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H.

IX. International Eurasian Hematology-Oncology Congress, Turkey, 17 - 20 October 2018, vol.71, pp.43

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73

AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.

4.İLAÇ VE TEDAVİ KONGRESİ, Cyprus (Kktc), 19 - 23 September 2018, pp.254

COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.

EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 June 2018

EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

The International Congress of BMT 2018, Busan, South Korea, 30 August - 01 September 2018

DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA

AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.

23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.

23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center

AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.

European Hematology Association, 14 - 17 June 2018

The Novel Translocation Of T(121) In Multiple Myeloma With Complex Karyotype

OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÖKER H.

23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data

AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.

European Hemtology Association, 14 - 17 June 2018

RISK FACTORS FOR EARLY MORTALITY IN MULTIPLE MYELOMA WITH DIFFERENT SURVIVAL TIME CUT-OFF POINTS: REAL-LIFE DATA

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.

23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

ANJİMMUNOBLASTİK T HÜCRELİ LENFOMA, ÇOK YÜZLÜ LENFOMA

OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HEZİYEV T., GÖKER H., BÜYÜKAŞIK Y.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018

PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.

2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Cyprus (Kktc), 4 - 06 May 2018

Common medical problems in adult patients with Hemophilia A: A single center experience

AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.

15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Turkey, 4 - 07 April 2018

DAMAK TUTULUMU İLE EKSTRAMEDÜLLER NÜKS OLAN RELAPS REFRAKTER MULTİPLE MYELOM OLGUSU

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H.

3. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Cyprus (Kktc), 29 - 31 March 2018

Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.

LYMPHOMA AND MYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.43-44

Donor Lymphocyte Infusions: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.

LYMPHOMAMYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.48

Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.

LYMPHOMA MYELOMA 2017, 26 - 28 October 2017

Donor Lymhocyte Infusion: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.

LYMHOMA MYELOMA 2017, 26 - 28 October 2017

EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.

INTERNATIONAL CONGRESS OF BMT 2018, Busan, South Korea, 30 August - 01 September 2018, vol.53

Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

2. Hematolojik Onkoloji Kongresi, Cyprus (Kktc), 16 - 19 February 2017

Determination of chemoterapoetic drugsensitivity subgroups of acute leukemia

Türk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.

The FEBS Journal, 3 - 08 September 2016

Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.373-374

A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINE

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39

AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIB

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., HAZNEDAROĞLU İ. C., DEMİROĞLU H., GÖKER H.

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39

SUCCESSFUL TREATMENT OF RESISTANT CHRONIC GRAFT VERSUS HOST DISEASE WITH EXTRACORPOREAL PHOTOPHERESIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WHO HAS UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., GÖKER H., ÖZCEBE O. İ.

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39

A COMPOSITE LYMPHOMA CASE

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., GÖKER H., HAZNEDAROĞLU İ. C.

6th International Eurasian Hematology Congress, Antalya, Turkey, 14 - 18 October 2015, vol.39

GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.690

Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors

Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Avcu F., Guner M., Misirci M., Elci P., Safali M., GÖKER H., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124

GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.

20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 June 2014

High-dose chemotherapy and autologons peripheral blood stein tell (PBSC) transplantation with initt-cryopreserved PBSCs in multiple myeloma

Goker H., Eliacik E., Buyukasik Y., Haznedaroglu I. C., Turgut M., Aksu S., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32

Philadelphia-positive acute lymphoblastic leukemia in daily practice: A multicenter experience.

Goker H., Tekgunduz E., Sari I., Pala C., Dogu M. H., Ozturk E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31

Laser methods for pharmaceutical pollutants removal

Smarandache A., Militaru A., GÖKER H., Pascu A., Pascu M.

6th Conference on Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies (ATOM-N), Constanta, Romania, 23 - 26 August 2012, vol.8411 Sustainable Development

Serological response to influenza vaccine haematopoetic stem cell transplantation patients

YALÇIN Ş., Kondolot M., Albayrak N., Altas B., Karacan Y., KUŞKONMAZ B. B., et al.

36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Austria, 21 - 24 March 2010, vol.45 Sustainable Development

Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT.

Mohty M., Labopin M., Janssen J. J. W. M., Mufti G. J., Cornelissen J. J., Milpied N., et al.

51st Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 5 - 08 December 2009, vol.114, pp.489

Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.

BEKSAÇ M., HAZNEDAR R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.

51st Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 5 - 08 December 2009, vol.114, pp.746-747

Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

Mohty M., Labopin M., Milpied N., Cornelissen J. J., Blaise D., Petersen E., et al.

50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.134-135

Haemostatic actions of the folkloric medicinal plant extract, Ankaferd Blood Stopper

GÖKER H., HAZNEDAROĞLU İ. C., Ercetin S., Kirazli S., Akman U., Ozturk Y., et al.

49th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 8 - 11 December 2007, vol.110

Books & Book Chapters

Klinik Pratikte Hematoloji

HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.

nobel tıp kitabevleri, Ankara, 2019

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI